1. Simeprevir versus telaprevir with peginterferon and ribavirin in previous null or partial responders with chronic hepatitis C virus genotype 1 infection (ATTAIN): a randomised, double-blind, non-inferiority phase 3 trial. Issue 1 (January 2015) Authors: Reddy, K Rajender; Zeuzem, Stefan; Zoulim, Fabien; Weiland, Ola; Horban, Andrzej; Stanciu, Carol; Villamil, Federico Guillermo; Andreone, Pietro; George, Jacob; Dammers, Elisabeth; Fu, Min; Kurland, Darryl; Lenz, Oliver; Ouwerkerk-Mahadevan, Sivi; Verbinnen, Thierry; Scott, Jane; Jessner, Wolfgang Journal: Lancet infectious diseases Issue: Volume 15:Issue 1(2015:Jan.) Page Start: 27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Simeprevir versus telaprevir with peginterferon and ribavirin in previous null or partial responders with chronic hepatitis C virus genotype 1 infection (ATTAIN): a randomised, double-blind, non-inferiority phase 3 trial. Issue 1 (January 2015) Authors: Reddy, K Rajender; Zeuzem, Stefan; Zoulim, Fabien; Weiland, Ola; Horban, Andrzej; Stanciu, Carol; Villamil, Federico Guillermo; Andreone, Pietro; George, Jacob; Dammers, Elisabeth; Fu, Min; Kurland, Darryl; Lenz, Oliver; Ouwerkerk-Mahadevan, Sivi; Verbinnen, Thierry; Scott, Jane; Jessner, Wolfgang Journal: Lancet infectious diseases Issue: Volume 15:Issue 1(2015:Jan.) Page Start: 27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗